Article Details

Atara Biotherapeutics (NASDAQ:ATRA) Rating Reiterated by HC Wainwright

Retrieved on: 2020-12-08 12:39:29

Tags for this article:

Click the tags to see associated articles and topics

Atara Biotherapeutics (NASDAQ:ATRA) Rating Reiterated by HC Wainwright. View article details on hiswai:

Excerpt

<b>Vanguard Group</b> Inc. now owns 4,642,630 shares of the biotechnology company's stock valued at $67,643,000 after buying an additional 820,304 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up